Clinical trial

Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy

NCT06828588

Study summary

ClinicalTrials.gov

Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy

Design: INTERVENTIONAL · Status: RECRUITING · Phase: EARLY_PHASE1

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention [68Ga]Ga-ABY-025 Find medicine records · Find other trials using this name

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-04-16

PhaseEARLY_PHASE1

Conditions

Locally Advanced Cancerunresolved

Metastatic Cancerverified · MONDO: metastatic malignant neoplasm

HER2unresolved

HER2 + Breast Cancer, HER2 + Gastric Cancer, Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinomaunresolved

HER 2 Low-expressing Breast Cancerunresolved

Interventions

[68Ga]Ga-ABY-025DRUG

Sponsors & collaborators

Vanderbilt-Ingram Cancer Centerlead sponsor

Mapped research locations

NashvilleTennessee, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06828588 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.